YBX3 and malignant colon neoplasm: Both YBX3 and lncRNA HEIH regulate the therapeutic response through certain common molecular mechanisms, but the role of the tumor regulation system composed of lncRNA-HEIH/YBX3 in the tumor microenvironment (TME) of diverse tumors, especially in colon cancer, has not been fully investigated.